{"gene":"CHN1","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":1993,"finding":"Alpha2-chimaerin (encoded by CHN1) is an SH2 domain-containing GTPase-activating protein (GAP) for the Rac GTPase (p21rac). It is generated by alternative splicing of the n-chimerin gene, adding an N-terminal SH2 domain to the phorbol ester receptor and GAP domains. Purified brain alpha2-chimaerin exhibited RacGAP activity stimulated by phosphatidylserine, and the SH2 domain bound phosphoproteins from PC12 cells whose phosphorylation increased in response to NGF.","method":"Protein purification from rat brain, in vitro RacGAP activity assay, recombinant E. coli expression, SH2 domain phosphoprotein binding assay, genomic cloning and splice site mapping","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro RacGAP activity with purified native and recombinant protein, multiple orthogonal methods","pmids":["8336731"],"is_preprint":false},{"year":2008,"finding":"Heterozygous missense mutations in CHN1 cause Duane's retraction syndrome (DURS2) by hyperactivating alpha2-chimaerin RacGAP activity. Several mutations enhance alpha2-chimaerin translocation to the cell membrane and/or its ability to self-associate (dimerize), resulting in increased RacGAP activity in vitro. Expression of mutant alpha2-chimaerin in chick embryos caused failure of oculomotor axons to innervate target extraocular muscles, establishing a gain-of-function role in ocular motor axon pathfinding.","method":"In vitro Rac-GTP activation assay, alpha2-chimaerin translocation assay (cell membrane fractionation), self-association/dimerization assay, in ovo chick embryo overexpression, genetic linkage and mutation analysis","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal in vitro and in vivo functional assays, replicated across multiple mutations in a high-impact study","pmids":["18653847"],"is_preprint":false},{"year":1996,"finding":"In myxoid chondrosarcoma with t(9;22)(q22-31;q11-12), the EWS gene fuses to CHN (encoding a steroid/thyroid receptor superfamily member at 9q22-31), producing a chimeric EWS-CHN fusion protein in which the C-terminal RNA-binding domain of EWS is replaced by the entire CHN protein (N-terminal domain, central DNA-binding domain, and C-terminal ligand-binding/dimerization domain).","method":"Chromosomal translocation mapping, cDNA cloning, RT-PCR, fusion gene characterization","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — fusion gene identified and characterized at molecular level; note this CHN is the nuclear receptor NOR1/CHN (NR4A3), not the chimaerin CHN1 RacGAP — however included as it is the first characterization of CHN gene structure","pmids":["8570200"],"is_preprint":false},{"year":2011,"finding":"A novel CHN1 mutation (p.Y148F) hyperactivates alpha2-chimaerin by enhancing its dimerization and membrane association, lowering total intracellular Rac-GTP. This expands the phenotypic spectrum of CHN1 gain-of-function mutations beyond Duane retraction syndrome to include vertical strabismus and supraduction deficits.","method":"Rac-GTP activation assay, alpha2-chimaerin translocation quantification, co-immunoprecipitation (dimerization assay), genetic linkage analysis","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal in vitro functional assays (RacGAP activity, translocation, co-IP) confirming gain-of-function mechanism","pmids":["21715346"],"is_preprint":false},{"year":2011,"finding":"Two novel CHN1 mutations (P141L and P252S) alter residues that participate in intramolecular interactions stabilizing the inactive closed conformation of alpha2-chimaerin, thus predicted to hyperactivate it. This demonstrates that the closed/inactive conformation of alpha2-chimaerin is maintained by specific intramolecular contacts that are disrupted by DRS-causing mutations.","method":"CHN1 gene sequencing, structural analysis of mutation positions in the closed-conformation model","journal":"Archives of ophthalmology (Chicago, Ill. : 1960)","confidence":"Medium","confidence_rationale":"Tier 3 — mutation analysis with structural inference; functional assays not performed in this paper","pmids":["21555619"],"is_preprint":false},{"year":2020,"finding":"A CHN1 variant p.(Phe213Val) in the C1 domain reduces Rac-GTP activity and enhances membrane translocation in response to phorbol-myristoyl acetate (PMA) in 293T cells, demonstrating that the C1 domain participates in both autoinhibition and phorbol ester-stimulated membrane recruitment of alpha2-chimaerin.","method":"Rac-GTP activation assay (293T cells), alpha2-chimaerin translocation assay (PMA stimulation), co-immunoprecipitation, in silico structural modeling","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — multiple in vitro functional assays in transfected cells, single lab","pmids":["33004823"],"is_preprint":false},{"year":2023,"finding":"TBX18 transcriptionally activates CHN1 by binding to its promoter region, and CHN1 in turn elevates RhoA activity (demonstrated by GST pull-down), establishing a TBX18→CHN1→RhoA signaling axis that promotes radioresistance in esophageal squamous cell carcinoma.","method":"Dual-luciferase reporter assay, ChIP assay (TBX18 binding to CHN1 promoter), GST pull-down (CHN1–RhoA interaction), CHN1 knockdown/overexpression with radiation treatment, xenograft mouse model","journal":"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP confirms direct transcriptional regulation, GST pull-down supports CHN1-RhoA interaction, supported by in vivo data; single lab","pmids":["37399907"],"is_preprint":false},{"year":2023,"finding":"Two novel CHN1 missense variants (p.His217Arg and p.Phe213Leu) cause dysplasia of ocular motor nerves when mutant CHN1 mRNAs are injected into zebrafish embryos, demonstrating that these variants are pathogenic and that CHN1 is required for ocular motor nerve development in vivo.","method":"Whole exome sequencing, zebrafish mRNA injection overexpression model, ocular motor nerve morphology assessment","journal":"Journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo zebrafish model with direct morphological readout of nerve dysplasia; single lab","pmids":["37853116"],"is_preprint":false}],"current_model":"CHN1 encodes alpha2-chimaerin, an SH2 domain-containing RacGAP that inactivates Rac GTPase; its activity is stimulated by phosphatidylserine and phorbol esters (via its C1 domain), and it is normally maintained in an autoinhibited closed conformation through intramolecular interactions; gain-of-function missense mutations that disrupt this closed conformation cause hyperactivation, enhanced membrane translocation, and self-dimerization, leading to excessive Rac-GTP hydrolysis and aberrant ocular motor axon pathfinding, resulting in Duane's retraction syndrome and related congenital cranial dysinnervation disorders."},"narrative":{"teleology":[{"year":1993,"claim":"The molecular identity and enzymatic activity of alpha2-chimaerin were established, resolving what protein the alternatively spliced CHN1 transcript encodes and demonstrating it functions as a Rac-specific GAP stimulated by phosphatidylserine.","evidence":"Purification of native protein from rat brain, reconstituted in vitro RacGAP assay, SH2 domain phosphoprotein binding in PC12 cells","pmids":["8336731"],"confidence":"High","gaps":["No in vivo functional role established","Endogenous upstream signals activating alpha2-chimaerin not identified","Structural basis for autoinhibition unknown"]},{"year":2008,"claim":"Gain-of-function CHN1 mutations were shown to cause Duane retraction syndrome by hyperactivating RacGAP activity through enhanced membrane translocation and self-dimerization, establishing that alpha2-chimaerin governs ocular motor axon pathfinding in vivo.","evidence":"Genetic linkage, in vitro Rac-GTP assays, membrane fractionation, dimerization assays, and chick embryo overexpression causing failure of oculomotor innervation","pmids":["18653847"],"confidence":"High","gaps":["Structural basis for the closed-to-open conformational switch not resolved at atomic level","Downstream effectors beyond Rac-GTP hydrolysis in axon guidance not identified","Whether loss-of-function produces a phenotype remains untested"]},{"year":2011,"claim":"Additional DRS-causing mutations expanded the phenotypic spectrum to vertical strabismus and confirmed that intramolecular contacts stabilizing the closed autoinhibited conformation are the common target of pathogenic variants.","evidence":"Rac-GTP assays, co-immunoprecipitation for dimerization, structural mapping of mutations to intramolecular contact residues","pmids":["21715346","21555619"],"confidence":"High","gaps":["No crystal structure of the full-length closed conformation was determined","Functional assays not performed for all structurally predicted mutations (P141L, P252S)"]},{"year":2020,"claim":"The C1 domain was shown to participate in both autoinhibition and phorbol ester-stimulated membrane recruitment, linking the diacylglycerol/phorbol ester-sensing module to conformational regulation of GAP activity.","evidence":"Rac-GTP assay and PMA-stimulated translocation assay in 293T cells expressing the F213V variant","pmids":["33004823"],"confidence":"Medium","gaps":["Endogenous lipid signals that activate C1 domain-mediated translocation in neurons not defined","Single variant studied; generalizability to other C1 domain residues unclear"]},{"year":2023,"claim":"CHN1 was placed in a transcriptional regulatory circuit in which TBX18 directly activates CHN1 expression, and CHN1 in turn elevates RhoA activity, revealing a non-neuronal role for CHN1 in promoting radioresistance in esophageal squamous cell carcinoma.","evidence":"ChIP and dual-luciferase assays for TBX18-CHN1 promoter binding; GST pull-down for CHN1-RhoA interaction; xenograft mouse model","pmids":["37399907"],"confidence":"Medium","gaps":["Mechanism by which a RacGAP elevates RhoA activity is not resolved","Whether this axis operates outside esophageal cancer context is unknown","Single lab finding; RhoA activation awaits independent confirmation"]},{"year":2023,"claim":"In vivo zebrafish modeling confirmed that novel CHN1 missense variants (H217R, F213L) are pathogenic, causing ocular motor nerve dysplasia and validating cross-species conservation of CHN1 function in cranial nerve development.","evidence":"Zebrafish embryo mRNA injection with morphological assessment of ocular motor nerves","pmids":["37853116"],"confidence":"Medium","gaps":["Biochemical characterization (RacGAP activity, translocation, dimerization) not performed for these specific variants","Endogenous zebrafish chn1 loss-of-function phenotype not reported"]},{"year":null,"claim":"A full structural understanding of how specific intramolecular contacts maintain the closed conformation and how upstream signals (endogenous DAG, receptor tyrosine kinase pathways) relieve autoinhibition in neuronal contexts remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No full-length crystal or cryo-EM structure of alpha2-chimaerin in closed and open states","Endogenous signaling inputs that activate alpha2-chimaerin during axon guidance not identified","Loss-of-function phenotype in mammalian models not characterized","Mechanism connecting Rac inactivation to specific downstream cytoskeletal effectors in oculomotor neurons unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,3,5]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[0,5]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,3,5]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1,5]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,6]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,7]}],"complexes":[],"partners":["RAC1","RHOA","TBX18"],"other_free_text":[]},"mechanistic_narrative":"CHN1 encodes alpha2-chimaerin, an SH2 domain-containing GTPase-activating protein (GAP) that inactivates Rac GTPase, with activity stimulated by phosphatidylserine and phorbol esters acting through its C1 domain [PMID:8336731, PMID:33004823]. The protein is normally maintained in an autoinhibited closed conformation by specific intramolecular contacts; disruption of these contacts by gain-of-function missense mutations enhances membrane translocation, self-dimerization, and RacGAP activity, resulting in excessive Rac-GTP hydrolysis and aberrant ocular motor axon pathfinding [PMID:18653847, PMID:21555619]. Heterozygous gain-of-function mutations in CHN1 cause Duane retraction syndrome (DURS2) and related congenital cranial dysinnervation disorders including vertical strabismus, as demonstrated by genetic linkage, in vitro functional assays, and in vivo models in chick and zebrafish [PMID:18653847, PMID:21715346, PMID:37853116]. CHN1 also elevates RhoA activity downstream of TBX18 transcriptional activation in esophageal squamous cell carcinoma, where a TBX18→CHN1→RhoA axis promotes radioresistance [PMID:37399907]."},"prefetch_data":{"uniprot":{"accession":"P15882","full_name":"N-chimaerin","aliases":["A-chimaerin","Alpha-chimerin","N-chimerin","NC","Rho GTPase-activating protein 2"],"length_aa":459,"mass_kda":53.2,"function":"GTPase-activating protein for p21-rac and a phorbol ester receptor. Involved in the assembly of neuronal locomotor circuits as a direct effector of EPHA4 in axon guidance","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P15882/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CHN1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000128656","cell_line_id":"CID000561","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"nucleoplasm","grade":3},{"compartment":"big_aggregates","grade":1}],"interactors":[{"gene":"ALDH1A1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000561","total_profiled":1310},"omim":[{"mim_id":"618186","title":"NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3","url":"https://www.omim.org/entry/618186"},{"mim_id":"618184","title":"NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2","url":"https://www.omim.org/entry/618184"},{"mim_id":"617368","title":"SH3 DOMAIN-BINDING PROTEIN 1; SH3BP1","url":"https://www.omim.org/entry/617368"},{"mim_id":"616407","title":"BROWN SYNDROME; BRWNS","url":"https://www.omim.org/entry/616407"},{"mim_id":"605253","title":"NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1","url":"https://www.omim.org/entry/605253"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":842.8}],"url":"https://www.proteinatlas.org/search/CHN1"},"hgnc":{"alias_symbol":["RhoGAP2","ARHGAP2","n-chimerin"],"prev_symbol":["CHN","DURS2"]},"alphafold":{"accession":"P15882","domains":[{"cath_id":"3.30.505.10","chopping":"17-135","consensus_level":"high","plddt":95.6867,"start":17,"end":135},{"cath_id":"3.30.60.20","chopping":"207-261","consensus_level":"high","plddt":94.3215,"start":207,"end":261},{"cath_id":"1.10.555.10","chopping":"276-453","consensus_level":"high","plddt":96.0118,"start":276,"end":453}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P15882","model_url":"https://alphafold.ebi.ac.uk/files/AF-P15882-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P15882-F1-predicted_aligned_error_v6.png","plddt_mean":86.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CHN1","jax_strain_url":"https://www.jax.org/strain/search?query=CHN1"},"sequence":{"accession":"P15882","fasta_url":"https://rest.uniprot.org/uniprotkb/P15882.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P15882/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P15882"}},"corpus_meta":[{"pmid":"8570200","id":"PMC_8570200","title":"Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma.","date":"1996","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8570200","citation_count":149,"is_preprint":false},{"pmid":"18653847","id":"PMC_18653847","title":"Human CHN1 mutations hyperactivate alpha2-chimaerin and cause Duane's retraction syndrome.","date":"2008","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/18653847","citation_count":127,"is_preprint":false},{"pmid":"21926414","id":"PMC_21926414","title":"The X-linked intellectual disability protein IL1RAPL1 regulates excitatory synapse formation by binding PTPδ and RhoGAP2.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21926414","citation_count":92,"is_preprint":false},{"pmid":"28310880","id":"PMC_28310880","title":"Proximate biochemical composition and caloric content calculated from elemental CHN analysis: a stoichiometric concept.","date":"1984","source":"Oecologia","url":"https://pubmed.ncbi.nlm.nih.gov/28310880","citation_count":92,"is_preprint":false},{"pmid":"10602520","id":"PMC_10602520","title":"Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma.","date":"1999","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10602520","citation_count":84,"is_preprint":false},{"pmid":"8336731","id":"PMC_8336731","title":"Alpha 2-chimerin, an SH2-containing GTPase-activating protein for the ras-related protein p21rac derived by alternate splicing of the human n-chimerin gene, is selectively expressed in brain regions and testes.","date":"1993","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8336731","citation_count":81,"is_preprint":false},{"pmid":"17197533","id":"PMC_17197533","title":"Magnetic resonance imaging evidence for widespread orbital dysinnervation in dominant Duane's retraction syndrome linked to the DURS2 locus.","date":"2007","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/17197533","citation_count":79,"is_preprint":false},{"pmid":"10602519","id":"PMC_10602519","title":"Fusion of the RBP56 and CHN genes in extraskeletal myxoid chondrosarcomas with translocation t(9;17)(q22;q11).","date":"1999","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10602519","citation_count":64,"is_preprint":false},{"pmid":"34724818","id":"PMC_34724818","title":"Candida albicans Isolates 529L and CHN1 Exhibit Stable Colonization of the Murine Gastrointestinal Tract.","date":"2021","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/34724818","citation_count":55,"is_preprint":false},{"pmid":"21715346","id":"PMC_21715346","title":"Expansion of the CHN1 strabismus phenotype.","date":"2011","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/21715346","citation_count":39,"is_preprint":false},{"pmid":"30377826","id":"PMC_30377826","title":"Genomic characterization and pathogenicity of porcine deltacoronavirus strain CHN-HG-2017 from China.","date":"2018","source":"Archives of virology","url":"https://pubmed.ncbi.nlm.nih.gov/30377826","citation_count":31,"is_preprint":false},{"pmid":"17961535","id":"PMC_17961535","title":"A mutation in CHN-1/CHIP suppresses muscle degeneration in Caenorhabditis elegans.","date":"2007","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17961535","citation_count":26,"is_preprint":false},{"pmid":"21555619","id":"PMC_21555619","title":"Two novel CHN1 mutations in 2 families with Duane retraction syndrome.","date":"2011","source":"Archives of ophthalmology (Chicago, Ill. : 1960)","url":"https://pubmed.ncbi.nlm.nih.gov/21555619","citation_count":24,"is_preprint":false},{"pmid":"33109127","id":"PMC_33109127","title":"Upregulation of miR-205 induces CHN1 expression, which is associated with the aggressive behaviour of cervical cancer cells and correlated with lymph node metastasis.","date":"2020","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33109127","citation_count":23,"is_preprint":false},{"pmid":"17197532","id":"PMC_17197532","title":"Two pedigrees segregating Duane's retraction syndrome as a dominant trait map to the DURS2 genetic locus.","date":"2007","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/17197532","citation_count":20,"is_preprint":false},{"pmid":"34238315","id":"PMC_34238315","title":"CHN1 promotes epithelial-mesenchymal transition via the Akt/GSK-3β/Snail pathway in cervical carcinoma.","date":"2021","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34238315","citation_count":15,"is_preprint":false},{"pmid":"20535495","id":"PMC_20535495","title":"Analysis of the CHN1 gene in patients with various types of congenital ocular motility disorders.","date":"2010","source":"Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie","url":"https://pubmed.ncbi.nlm.nih.gov/20535495","citation_count":12,"is_preprint":false},{"pmid":"25532047","id":"PMC_25532047","title":"NMR study of CHN hydrogen bond and proton transfer in 1,1-dinitroethane complex with 2,4,6-trimethylpyridine.","date":"2015","source":"The journal of physical chemistry. A","url":"https://pubmed.ncbi.nlm.nih.gov/25532047","citation_count":8,"is_preprint":false},{"pmid":"32759029","id":"PMC_32759029","title":"Application of the APE2-CHN and RITE2-CHN scores for autoimmune seizures and epilepsy in Chinese patients: A retrospective study.","date":"2020","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/32759029","citation_count":8,"is_preprint":false},{"pmid":"35424132","id":"PMC_35424132","title":"Elucidating the intercalation of methylated 1,10-phenanthroline with DNA: the important weight of the CH/H interactions and the selectivity of CH/π and CH/n interactions.","date":"2021","source":"RSC advances","url":"https://pubmed.ncbi.nlm.nih.gov/35424132","citation_count":8,"is_preprint":false},{"pmid":"33667650","id":"PMC_33667650","title":"CHN1 and duane retraction syndrome: Expanding the phenotype to cranial nerves development disease.","date":"2021","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33667650","citation_count":6,"is_preprint":false},{"pmid":"38463317","id":"PMC_38463317","title":"Synthesis of Cross-Linked and Sterilized Water-Soluble Electrospun Nanofiber Biomatrix of Streptomycin-Imbedded PVA/CHN/β-CD for Wound Healing.","date":"2024","source":"ACS omega","url":"https://pubmed.ncbi.nlm.nih.gov/38463317","citation_count":5,"is_preprint":false},{"pmid":"34152250","id":"PMC_34152250","title":"Bioinformatics-based analysis of the association between the A1-chimaerin (CHN1) gene and gastric cancer.","date":"2021","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/34152250","citation_count":4,"is_preprint":false},{"pmid":"33004823","id":"PMC_33004823","title":"Identification of a novel CHN1 p.(Phe213Val) variant in a large Han Chinese family with congenital Duane retraction syndrome.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33004823","citation_count":4,"is_preprint":false},{"pmid":"29031989","id":"PMC_29031989","title":"CHN1 gene mutation analysis in patients with Duane retraction syndrome.","date":"2017","source":"Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus","url":"https://pubmed.ncbi.nlm.nih.gov/29031989","citation_count":4,"is_preprint":false},{"pmid":"36985290","id":"PMC_36985290","title":"Identification of Z-Tyr-Ala-CHN2, a Cathepsin L Inhibitor with Broad-Spectrum Cell-Specific Activity against Coronaviruses, including SARS-CoV-2.","date":"2023","source":"Microorganisms","url":"https://pubmed.ncbi.nlm.nih.gov/36985290","citation_count":4,"is_preprint":false},{"pmid":"32219675","id":"PMC_32219675","title":"Efficacy and Safety of Dulaglutide Monotherapy Compared to Glimepiride in Oral Antihyperglycemic Medication-Naïve Chinese patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN1.","date":"2020","source":"Diabetes therapy : research, treatment and education of diabetes and related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/32219675","citation_count":4,"is_preprint":false},{"pmid":"35583797","id":"PMC_35583797","title":"Study Design and Baseline Characteristics of Patients with T2DM in the Post-marketing Safety Study of Dulaglutide in China (TRUST-CHN).","date":"2022","source":"Diabetes therapy : research, treatment and education of diabetes and related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/35583797","citation_count":4,"is_preprint":false},{"pmid":"32857293","id":"PMC_32857293","title":"Efficacy and Safety of Once-Weekly Dulaglutide in Elderly Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN Studies.","date":"2020","source":"Diabetes therapy : research, treatment and education of diabetes and related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/32857293","citation_count":3,"is_preprint":false},{"pmid":"39812067","id":"PMC_39812067","title":"COL1A1, COL1A2, CHN1, and FN1 Promote Tumorogenesis and Act as Markers of Diagnosis and Survival in Gastric Cancer Patients.","date":"2025","source":"Current pharmaceutical biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/39812067","citation_count":3,"is_preprint":false},{"pmid":"26186028","id":"PMC_26186028","title":"Influence of Foot-and-Mouth Disease Virus O/CHN/Mya98/33-P Strain Leader Protein on Viral Replication and Host Innate Immunity.","date":"2015","source":"Viral immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26186028","citation_count":3,"is_preprint":false},{"pmid":"38356699","id":"PMC_38356699","title":"Case report: Identification of a novel variant p.Gly215Arg in the CHN1 gene causing Moebius syndrome.","date":"2024","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38356699","citation_count":2,"is_preprint":false},{"pmid":"37399907","id":"PMC_37399907","title":"TBX18 knockdown sensitizes esophageal squamous cell carcinoma to radiotherapy by blocking the CHN1/RhoA axis.","date":"2023","source":"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/37399907","citation_count":1,"is_preprint":false},{"pmid":"19342283","id":"PMC_19342283","title":"HGD-Chn: The Database of Genome Diversity and Variation for Chinese Populations.","date":"2009","source":"Legal medicine (Tokyo, Japan)","url":"https://pubmed.ncbi.nlm.nih.gov/19342283","citation_count":1,"is_preprint":false},{"pmid":"39156926","id":"PMC_39156926","title":"Dynamics of CH/n hydrogen bond networks probed by time-resolved CARS spectroscopy.","date":"2024","source":"Chemical science","url":"https://pubmed.ncbi.nlm.nih.gov/39156926","citation_count":1,"is_preprint":false},{"pmid":"38509018","id":"PMC_38509018","title":"Special clinical features with a novel mutation site of CHN1 gene in a Chinese family with Duane retraction syndrome.","date":"2024","source":"Strabismus","url":"https://pubmed.ncbi.nlm.nih.gov/38509018","citation_count":0,"is_preprint":false},{"pmid":"37853116","id":"PMC_37853116","title":"Two novel CHN1 variants identified in Duane retraction syndrome pedigrees disrupt development of ocular motor nerves in zebrafish.","date":"2023","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37853116","citation_count":0,"is_preprint":false},{"pmid":"40227916","id":"PMC_40227916","title":"Three-Dimensional CH/π and CH/N Interactions from Quantum-Mechanical and Database Analyses.","date":"2025","source":"Journal of chemical information and modeling","url":"https://pubmed.ncbi.nlm.nih.gov/40227916","citation_count":0,"is_preprint":false},{"pmid":"41333466","id":"PMC_41333466","title":"CHN1 as a potential predictive genetic biomarker for atopic dermatitis-related depression.","date":"2025","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/41333466","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":22084,"output_tokens":2275,"usd":0.050188},"stage2":{"model":"claude-opus-4-6","input_tokens":5558,"output_tokens":2053,"usd":0.118673},"total_usd":0.168861,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"Alpha2-chimaerin (encoded by CHN1) is an SH2 domain-containing GTPase-activating protein (GAP) for the Rac GTPase (p21rac). It is generated by alternative splicing of the n-chimerin gene, adding an N-terminal SH2 domain to the phorbol ester receptor and GAP domains. Purified brain alpha2-chimaerin exhibited RacGAP activity stimulated by phosphatidylserine, and the SH2 domain bound phosphoproteins from PC12 cells whose phosphorylation increased in response to NGF.\",\n      \"method\": \"Protein purification from rat brain, in vitro RacGAP activity assay, recombinant E. coli expression, SH2 domain phosphoprotein binding assay, genomic cloning and splice site mapping\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro RacGAP activity with purified native and recombinant protein, multiple orthogonal methods\",\n      \"pmids\": [\"8336731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Heterozygous missense mutations in CHN1 cause Duane's retraction syndrome (DURS2) by hyperactivating alpha2-chimaerin RacGAP activity. Several mutations enhance alpha2-chimaerin translocation to the cell membrane and/or its ability to self-associate (dimerize), resulting in increased RacGAP activity in vitro. Expression of mutant alpha2-chimaerin in chick embryos caused failure of oculomotor axons to innervate target extraocular muscles, establishing a gain-of-function role in ocular motor axon pathfinding.\",\n      \"method\": \"In vitro Rac-GTP activation assay, alpha2-chimaerin translocation assay (cell membrane fractionation), self-association/dimerization assay, in ovo chick embryo overexpression, genetic linkage and mutation analysis\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal in vitro and in vivo functional assays, replicated across multiple mutations in a high-impact study\",\n      \"pmids\": [\"18653847\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"In myxoid chondrosarcoma with t(9;22)(q22-31;q11-12), the EWS gene fuses to CHN (encoding a steroid/thyroid receptor superfamily member at 9q22-31), producing a chimeric EWS-CHN fusion protein in which the C-terminal RNA-binding domain of EWS is replaced by the entire CHN protein (N-terminal domain, central DNA-binding domain, and C-terminal ligand-binding/dimerization domain).\",\n      \"method\": \"Chromosomal translocation mapping, cDNA cloning, RT-PCR, fusion gene characterization\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — fusion gene identified and characterized at molecular level; note this CHN is the nuclear receptor NOR1/CHN (NR4A3), not the chimaerin CHN1 RacGAP — however included as it is the first characterization of CHN gene structure\",\n      \"pmids\": [\"8570200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"A novel CHN1 mutation (p.Y148F) hyperactivates alpha2-chimaerin by enhancing its dimerization and membrane association, lowering total intracellular Rac-GTP. This expands the phenotypic spectrum of CHN1 gain-of-function mutations beyond Duane retraction syndrome to include vertical strabismus and supraduction deficits.\",\n      \"method\": \"Rac-GTP activation assay, alpha2-chimaerin translocation quantification, co-immunoprecipitation (dimerization assay), genetic linkage analysis\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal in vitro functional assays (RacGAP activity, translocation, co-IP) confirming gain-of-function mechanism\",\n      \"pmids\": [\"21715346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Two novel CHN1 mutations (P141L and P252S) alter residues that participate in intramolecular interactions stabilizing the inactive closed conformation of alpha2-chimaerin, thus predicted to hyperactivate it. This demonstrates that the closed/inactive conformation of alpha2-chimaerin is maintained by specific intramolecular contacts that are disrupted by DRS-causing mutations.\",\n      \"method\": \"CHN1 gene sequencing, structural analysis of mutation positions in the closed-conformation model\",\n      \"journal\": \"Archives of ophthalmology (Chicago, Ill. : 1960)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — mutation analysis with structural inference; functional assays not performed in this paper\",\n      \"pmids\": [\"21555619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"A CHN1 variant p.(Phe213Val) in the C1 domain reduces Rac-GTP activity and enhances membrane translocation in response to phorbol-myristoyl acetate (PMA) in 293T cells, demonstrating that the C1 domain participates in both autoinhibition and phorbol ester-stimulated membrane recruitment of alpha2-chimaerin.\",\n      \"method\": \"Rac-GTP activation assay (293T cells), alpha2-chimaerin translocation assay (PMA stimulation), co-immunoprecipitation, in silico structural modeling\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple in vitro functional assays in transfected cells, single lab\",\n      \"pmids\": [\"33004823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TBX18 transcriptionally activates CHN1 by binding to its promoter region, and CHN1 in turn elevates RhoA activity (demonstrated by GST pull-down), establishing a TBX18→CHN1→RhoA signaling axis that promotes radioresistance in esophageal squamous cell carcinoma.\",\n      \"method\": \"Dual-luciferase reporter assay, ChIP assay (TBX18 binding to CHN1 promoter), GST pull-down (CHN1–RhoA interaction), CHN1 knockdown/overexpression with radiation treatment, xenograft mouse model\",\n      \"journal\": \"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP confirms direct transcriptional regulation, GST pull-down supports CHN1-RhoA interaction, supported by in vivo data; single lab\",\n      \"pmids\": [\"37399907\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Two novel CHN1 missense variants (p.His217Arg and p.Phe213Leu) cause dysplasia of ocular motor nerves when mutant CHN1 mRNAs are injected into zebrafish embryos, demonstrating that these variants are pathogenic and that CHN1 is required for ocular motor nerve development in vivo.\",\n      \"method\": \"Whole exome sequencing, zebrafish mRNA injection overexpression model, ocular motor nerve morphology assessment\",\n      \"journal\": \"Journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo zebrafish model with direct morphological readout of nerve dysplasia; single lab\",\n      \"pmids\": [\"37853116\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CHN1 encodes alpha2-chimaerin, an SH2 domain-containing RacGAP that inactivates Rac GTPase; its activity is stimulated by phosphatidylserine and phorbol esters (via its C1 domain), and it is normally maintained in an autoinhibited closed conformation through intramolecular interactions; gain-of-function missense mutations that disrupt this closed conformation cause hyperactivation, enhanced membrane translocation, and self-dimerization, leading to excessive Rac-GTP hydrolysis and aberrant ocular motor axon pathfinding, resulting in Duane's retraction syndrome and related congenital cranial dysinnervation disorders.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CHN1 encodes alpha2-chimaerin, an SH2 domain-containing GTPase-activating protein (GAP) that inactivates Rac GTPase, with activity stimulated by phosphatidylserine and phorbol esters acting through its C1 domain [PMID:8336731, PMID:33004823]. The protein is normally maintained in an autoinhibited closed conformation by specific intramolecular contacts; disruption of these contacts by gain-of-function missense mutations enhances membrane translocation, self-dimerization, and RacGAP activity, resulting in excessive Rac-GTP hydrolysis and aberrant ocular motor axon pathfinding [PMID:18653847, PMID:21555619]. Heterozygous gain-of-function mutations in CHN1 cause Duane retraction syndrome (DURS2) and related congenital cranial dysinnervation disorders including vertical strabismus, as demonstrated by genetic linkage, in vitro functional assays, and in vivo models in chick and zebrafish [PMID:18653847, PMID:21715346, PMID:37853116]. CHN1 also elevates RhoA activity downstream of TBX18 transcriptional activation in esophageal squamous cell carcinoma, where a TBX18→CHN1→RhoA axis promotes radioresistance [PMID:37399907].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"The molecular identity and enzymatic activity of alpha2-chimaerin were established, resolving what protein the alternatively spliced CHN1 transcript encodes and demonstrating it functions as a Rac-specific GAP stimulated by phosphatidylserine.\",\n      \"evidence\": \"Purification of native protein from rat brain, reconstituted in vitro RacGAP assay, SH2 domain phosphoprotein binding in PC12 cells\",\n      \"pmids\": [\"8336731\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No in vivo functional role established\",\n        \"Endogenous upstream signals activating alpha2-chimaerin not identified\",\n        \"Structural basis for autoinhibition unknown\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Gain-of-function CHN1 mutations were shown to cause Duane retraction syndrome by hyperactivating RacGAP activity through enhanced membrane translocation and self-dimerization, establishing that alpha2-chimaerin governs ocular motor axon pathfinding in vivo.\",\n      \"evidence\": \"Genetic linkage, in vitro Rac-GTP assays, membrane fractionation, dimerization assays, and chick embryo overexpression causing failure of oculomotor innervation\",\n      \"pmids\": [\"18653847\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for the closed-to-open conformational switch not resolved at atomic level\",\n        \"Downstream effectors beyond Rac-GTP hydrolysis in axon guidance not identified\",\n        \"Whether loss-of-function produces a phenotype remains untested\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Additional DRS-causing mutations expanded the phenotypic spectrum to vertical strabismus and confirmed that intramolecular contacts stabilizing the closed autoinhibited conformation are the common target of pathogenic variants.\",\n      \"evidence\": \"Rac-GTP assays, co-immunoprecipitation for dimerization, structural mapping of mutations to intramolecular contact residues\",\n      \"pmids\": [\"21715346\", \"21555619\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No crystal structure of the full-length closed conformation was determined\",\n        \"Functional assays not performed for all structurally predicted mutations (P141L, P252S)\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"The C1 domain was shown to participate in both autoinhibition and phorbol ester-stimulated membrane recruitment, linking the diacylglycerol/phorbol ester-sensing module to conformational regulation of GAP activity.\",\n      \"evidence\": \"Rac-GTP assay and PMA-stimulated translocation assay in 293T cells expressing the F213V variant\",\n      \"pmids\": [\"33004823\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Endogenous lipid signals that activate C1 domain-mediated translocation in neurons not defined\",\n        \"Single variant studied; generalizability to other C1 domain residues unclear\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"CHN1 was placed in a transcriptional regulatory circuit in which TBX18 directly activates CHN1 expression, and CHN1 in turn elevates RhoA activity, revealing a non-neuronal role for CHN1 in promoting radioresistance in esophageal squamous cell carcinoma.\",\n      \"evidence\": \"ChIP and dual-luciferase assays for TBX18-CHN1 promoter binding; GST pull-down for CHN1-RhoA interaction; xenograft mouse model\",\n      \"pmids\": [\"37399907\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism by which a RacGAP elevates RhoA activity is not resolved\",\n        \"Whether this axis operates outside esophageal cancer context is unknown\",\n        \"Single lab finding; RhoA activation awaits independent confirmation\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"In vivo zebrafish modeling confirmed that novel CHN1 missense variants (H217R, F213L) are pathogenic, causing ocular motor nerve dysplasia and validating cross-species conservation of CHN1 function in cranial nerve development.\",\n      \"evidence\": \"Zebrafish embryo mRNA injection with morphological assessment of ocular motor nerves\",\n      \"pmids\": [\"37853116\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Biochemical characterization (RacGAP activity, translocation, dimerization) not performed for these specific variants\",\n        \"Endogenous zebrafish chn1 loss-of-function phenotype not reported\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A full structural understanding of how specific intramolecular contacts maintain the closed conformation and how upstream signals (endogenous DAG, receptor tyrosine kinase pathways) relieve autoinhibition in neuronal contexts remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No full-length crystal or cryo-EM structure of alpha2-chimaerin in closed and open states\",\n        \"Endogenous signaling inputs that activate alpha2-chimaerin during axon guidance not identified\",\n        \"Loss-of-function phenotype in mammalian models not characterized\",\n        \"Mechanism connecting Rac inactivation to specific downstream cytoskeletal effectors in oculomotor neurons unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 3, 5]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [0, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 3, 5]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 6]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 7]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"RAC1\",\n      \"RHOA\",\n      \"TBX18\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}